Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable Inferior Vena Cava (IVC) Filter

Signals continued investment in accelerated cardiovascular technology development MENLO PARK, Calif., June 14, 2022 /PRNewswire/ -- Cordis-X today announced an $11.5 million Series F investment in Adient Medical, maker of a next-generation absorbable inferior vena cava (IVC) filter that...

Click to view original post